Afisi Ismaila

Afisi Ismaila is a highly experienced professional with a background in health research, evidence evaluation, and health economics.

Currently serving as the Global Value Evidence Leader for the COPD Portfolio at GSK, Afisi Ismaila plays a crucial role in gathering, analyzing, and presenting data to showcase the value of products within the chronic obstructive pulmonary disease sector.

Having previously held roles at prominent institutions such as McMaster University and various positions at GSK, including Director of Value Evidence and Outcomes in the Respiratory Therapy Area, Program Leader in Health Economics and Outcomes Research, and Senior Biostatistician and Health Outcomes Manager in primary care, oncology, and infectious diseases, Afisi Ismaila possesses a diverse skill set that encompasses biostatistics, health outcomes research, and epidemiology.

His experience as an Adjunct Assistant Professor in Departments of Health Research Methods, Evidence, and Impact, as well as Clinical Epidemiology and Biostatistics at McMaster University, showcases his commitment to academia and research dissemination.

Afisi Ismaila's professional journey includes a blend of academia and industry expertise, where he has contributed significantly to the fields of health economics, outcomes research, and evidence-based medicine.

With a strong background in value evidence generation and an impressive track record in leadership roles within the healthcare sector, Afisi Ismaila stands out as a seasoned professional with a profound understanding of health-related data analysis and interpretation.